Clinical Trial Update: Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether bumetanide can improve cognitive functions in individuals with Down syndrome. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

Sponsor: Stefano Vicari | Conditions: Down Syndrome | Phase 2 | Status: RECRUITING